Airway & Compression Techniques for Cardiac Arrest
(FACT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Airway & Compression Techniques for Cardiac Arrest?
Research shows that the i-gel, a device used to keep the airway open, is easier and faster to insert during CPR, which can help maintain effective chest compressions. Additionally, studies suggest that chest compression rates of 100-120 per minute are recommended, but higher rates may increase blood flow, potentially improving outcomes during cardiac arrest.12345
Is the airway and compression technique for cardiac arrest safe for humans?
How does the treatment using Compression Rate and i-gel differ from other treatments for cardiac arrest?
The treatment using Compression Rate and i-gel is unique because it focuses on optimizing the rate of chest compressions during CPR and uses the i-gel airway device, which is a simple, non-inflatable mask that provides a clear airway quickly and effectively, potentially improving outcomes during cardiac arrest compared to traditional methods.1112131415
What is the purpose of this trial?
The First responder Airway \& Compression rate Trial (FACT) Study will address basic life support (BLS) treatments administered by Emergency Medical Services (EMS) first responders to patients who suffer a sudden circulatory (pulseless) collapse, referred to as sudden out-of-hospital cardiac arrest (SCA). The investigators propose a randomized controlled trial among persons who suffer SCA to compare these two rescue breathing approaches (standard Bag Valve Mask vs i-gel) along with evaluating a more precise chest compression rate within the range of 100-120 compressions per minute during CPR. Importantly, each of these treatments fall within established resuscitation guidelines and are already administered as part of standard care in clinical practice. Thus this proposed trial will essentially be comparing one standard-of-care treatment against another standard-of-care treatment.The study will address two primary aims:Aim 1: To compare survival to hospital discharge between SCA patients randomized to BVM versus the i-gel for rescue breathing. The hypothesis is that treatment with i-gel will result in a higher rate of survival to hospital discharge than BVM.Aim 2: To compare survival to hospital discharge between SCA patients randomized to chest compression rates of 100 versus 110 versus 120 per minute. The hypothesis is that treatment with 100 chest compressions per minute will result in a higher rate of survival to hospital discharge than compression rates of 110 or 120 per minute.
Research Team
Thomas Rea, MD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for adults in Seattle and greater King County who experience a sudden, non-traumatic cardiac arrest outside of the hospital where EMS will attempt resuscitation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive basic life support treatments including rescue breathing with either BVM or i-gel and chest compressions at varying rates
Follow-up
Participants are monitored for survival to hospital discharge and neurological function
Treatment Details
Interventions
- Compression Rate
- i-gel
Compression Rate is already approved in United States, European Union, Canada for the following indications:
- Cardiac arrest
- Sudden circulatory collapse
- Out-of-hospital cardiac arrest
- Cardiac emergency
- Sudden cardiac arrest
- Cardiopulmonary emergency
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor